The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Masimo's revenues will expand 11.1% and EPS will grow 3.7%.
The average estimate for revenue is $136.4 million. On the bottom line, the average EPS estimate is $0.28.
Last quarter, Masimo chalked up revenue of $135.9 million. GAAP reported sales were 13% higher than the prior-year quarter's $119.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.28. GAAP EPS of $0.28 for Q1 were 3.7% higher than the prior-year quarter's $0.27 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 66.8%, 30 basis points better than the prior-year quarter. Operating margin was 17.3%, 140 basis points worse than the prior-year quarter. Net margin was 12.2%, 100 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $549.1 million. The average EPS estimate is $1.14.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 166 members out of 175 rating the stock outperform, and nine members rating it underperform. Among 39 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 38 give Masimo a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Masimo is hold, with an average price target of $23.81.
Is Masimo the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Masimo to My Watchlist.